TLSA — Tiziana Life Sciences Share News
0.000.00%
Last trade - 00:00- $137.84m
- $134.28m
Brief: Tiziana Life Sciences Starts Enrollment Of The First Patient Cohort In Its Intermediate Size Patient Population Expanded Access Program To Evaluate Foralumab In Non-Active Secondary Multiple Sclerosis Patients
U.S. STOCKS ON THE MOVE-Novavax, Tiziana, Hempacco
Tiziana to seek FDA's nod to begin Alzheimer's drug trial; shares up
Brief: Tiziana Life Sciences Plans To Submit Ind For Phase 1 Trial Of Intranasal Foralumab In Alzheimer's Disease Patients
Brief: Tiziana Life Sciences Announces Purchase Of Common Shares By Executive Chairman
Brief: Tiziana Life Sciences Announces Grant Received By The Brigham And Women’S Hospital To Explore The Use Of Intranasal Anti-Cd3 Mab In Amyotrophic Lateral Sclerosis
Brief: Tiziana Life Sciences Announces Purchase Of Common Shares By Chief Medical Officer
Brief: Tiziana Life Sciences Announces Purchase Of Common Shares By Executive Chairman
Brief: Tiziana Life Sciences Announces Purchase Of Common Shares By Executive Chairman
Brief: Tiziana Life Sciences Reports Resignation Of CEO
Brief: Tiziana Life Sciences Ltd. Receives Nasdaq Deficiency Notice
Brief: Tiziana Life Sciences Announces Purchase Of Common Shares By Executive Chairman
Brief: Tiziana Life Sciences Announces Purchase Of Common Shares By Executive Chairman
Brief: Tiziana Life Sciences Announces Results From Second Patient With Secondary Progressive Multiple Sclerosis Following Three Months Of Dosing With Intranasal Foralumab
Brief: Tiziana Life Sciences Files Annual Report To Regain Nasdaq Compliance
Brief: FDA Grants Permission To Enroll Up To 8 Additional Secondary Progressive Multiple Sclerosis Patients In Expanded Access Program With Intranasal Foralumab
U.S. STOCKS ON THE MOVE-Icosavax, MEI Pharma, Clever Leaves
Tiziana gains on starting human trial for Crohn's disease oral therapy
Brief: Tiziana Announces Initiation Of Phase 1B Clinical Trial In Crohn's Disease Patients To Evaluate Oral Capsules Of Foralumab, A Fully Human Anti-CD3 Monoclonal Antibody